We are a biotechnology company focused on applying stem cell technology in the field of regenerative medicine to bring effective, patient-specific therapies to the bedside

FT's Science Editor interviews ACT's Chairman and CEO William M. Caldwell IV

Latest Blog Posts

08/01/2010 Biotech industry one giant step closer to bringing embryonic stem cell-based cures and treatments into the clinic. 08/17/2010 HuffPost: “ESCR is the gold standard by which every other method must be judged” 08/11/2010 Big Pharma losing sleep over stem cell approval?
OTCBB:ACTC.OB

Get medical facts.

Doctor holding patient file

For doctors and patient advocates. We want to exchange knowledge and ideas with you

Research with embryonic stem cells is quickly moving from the lab to the clinic, and the promise of these "master cells" is fast becoming a reality. Stay informed and engage in an active dialogue about the latest developments in regenerative medicine that could revolutionize medicine and patient care.

Contribute.
visit our regenerative medicine blog
See ACT's Profile on LinkedIn public group on Linkedin professionals in biotechnology & regenerative medicine

Invest in a cure.

Large Stocker Ticker

An Investment in ACTC stock:
An Investment in the future of medicine.

An investment in the regenerative medicine sector can help hasten the day that treatments using pluripotent stem cells enter the clinic. Treatments and cures using these "master" cells have the potential to change the field of medicine, with long-term revenue potential in the hundreds of billions of dollars.

Invest.
join the investment blog
Stock talk on Seeking Alpha See ACT's Google Group See ACT's Profile on LinkedIn stock talk on seeking alpha
& investor only pages

Learn the truth.

Man with arms outstretched to sky

For those living with a debilitating disease or condition, and their loved ones

The day is drawing nearer when a host of debilitating diseases and conditions can be not only treated but actually cured via therapies using embryonic stem cells. Stay abreast of the latest developments and meet others interested in this promising field.

Discuss.
ask us on the public blog
Join the Cause on Facebook Follow ACT on Twitter follow us on twitter
join the cause on facebook

Advanced Cell Technology Press Releases

Date
Title
08/30/2010
08/24/2010
08/16/2010
07/27/2010
06/16/2010
06/11/2010
05/25/2010
05/12/2010
05/10/2010